Background and purpose: Bladder cancer is the most common malignant tumour in the
urinary system, with a high incidence and recurrence rate. While the incidence of bladder …

Active surveillance (AS) has been introduced as an observational strategy to delay or avoid
curative treatment without compromising long‐term cancer‐specific survival. The 10 studies …

PURPOSE: Prostate specific antigen and digital rectal examination have low specificity for
detecting prostate cancer and they poorly predict the presence of aggressive disease. Urine …

More than 50% of prostate cancers have undergone a genomic reorganization that
juxtaposes the androgen-regulated promoter of TMPRSS2 and the protein coding parts of …

Although the routine use of serum prostate-specific antigen (PSA) testing has undoubtedly
increased prostate cancer (PCa) detection, one of its main drawbacks is its lack of specificity …

Prostate cancer (PCa) is one of the most common male malignancies. Serum prostate-
specific antigen (PSA) is one of the most valuable biomarkers in tumor biology and remains …

BACKGROUND There is controversy in the literature on the role of the fusion TMPRSS2‐
ERG in the pathogenesis and progression of prostate cancer. The quantitative differences in …

In order to successfully cure patients with prostate cancer (PCa), it is important to detect the
disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they …

BACKGROUND Prostate health index (phi) and prostate cancer antigen 3 (PCA3) have
been recently proposed as novel biomarkers for prostate cancer (PCa). We assessed the …

Prostate cancer is a heterogeneous disease with disparate outcomes. Traditional clinical
parameters are limited in their ability to differentiate between these cases, and there is …